Search research articles
Contact Us
Filters
Showing results (1-10 of 16) with videos related to
Page
of 2
Sort By:
Statistics in Medicine
|
December 6, 2012
Interim treatment selection with a flexible selection margin in clinical trials
Yujun Wu, Peng-Liang Zhao
Statistics in Medicine
|
August 21, 2002
A note on ANOVA assumptions and robust analysis for a cross-over study
Xun Chen, Peng-Liang Zhao, Ji Zhang
Journal of Biopharmaceutical Statistics
|
April 2, 2010
Sample size calculation for thorough QT/QTc study considering various factors related to multiple time points
Zhaoling Meng, Robert Kringle, Xun Chen, et al.
Contemporary Clinical Trials
|
July 2, 2013
New paradigm for drug developments--from emerging market statistical perspective
Hui Quan, Xun Chen, Ji Zhang, et al.
Pharmaceutical Statistics
|
June 6, 2009
Sample size considerations for Japanese patients in a multi-regional trial based on MHLW guidance
Hui Quan, Peng-Liang Zhao, Ji Zhang, et al.
Journal of Biopharmaceutical Statistics
|
September 6, 2017
Considerations for pediatric trial designs and analyses
Meehyung Cho, Zhiying Qiu, Jenny Ye, et al.
Journal of Biopharmaceutical Statistics
|
January 22, 2013
Considerations for design and data analysis of noninferiority/superiority cardiovascular trials
Hui Quan, Mingyu Li, Peng-Liang Zhao, et al.
Statistics in Medicine
|
August 3, 2012
Empirical shrinkage estimator for consistency assessment of treatment effects in multi-regional clinical trials
Hui Quan, Mingyu Li, Weichung Joe Shih, et al.
Statistics in Medicine
|
February 12, 2014
Multi-regional clinical trial design and consistency assessment of treatment effects
Hui Quan, Xuezhou Mao, Joshua Chen, et al.
Contemporary Clinical Trials
|
April 30, 2017
Example-based illustrations of design, conduct, analysis and result interpretation of multi-regional clinical trials
Hui Quan, Xuezhou Mao, Yoko Tanaka, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 16) with videos related to
Sort By:
Page
of 2
Statistics in Medicine
|
December 6, 2012
Interim treatment selection with a flexible selection margin in clinical trials
Yujun Wu, Peng-Liang Zhao
Statistics in Medicine
|
August 21, 2002
A note on ANOVA assumptions and robust analysis for a cross-over study
Xun Chen, Peng-Liang Zhao, Ji Zhang
Journal of Biopharmaceutical Statistics
|
April 2, 2010
Sample size calculation for thorough QT/QTc study considering various factors related to multiple time points
Zhaoling Meng, Robert Kringle, Xun Chen, et al.
Contemporary Clinical Trials
|
July 2, 2013
New paradigm for drug developments--from emerging market statistical perspective
Hui Quan, Xun Chen, Ji Zhang, et al.
Pharmaceutical Statistics
|
June 6, 2009
Sample size considerations for Japanese patients in a multi-regional trial based on MHLW guidance
Hui Quan, Peng-Liang Zhao, Ji Zhang, et al.
Journal of Biopharmaceutical Statistics
|
September 6, 2017
Considerations for pediatric trial designs and analyses
Meehyung Cho, Zhiying Qiu, Jenny Ye, et al.
Journal of Biopharmaceutical Statistics
|
January 22, 2013
Considerations for design and data analysis of noninferiority/superiority cardiovascular trials
Hui Quan, Mingyu Li, Peng-Liang Zhao, et al.
Statistics in Medicine
|
August 3, 2012
Empirical shrinkage estimator for consistency assessment of treatment effects in multi-regional clinical trials
Hui Quan, Mingyu Li, Weichung Joe Shih, et al.
Statistics in Medicine
|
February 12, 2014
Multi-regional clinical trial design and consistency assessment of treatment effects
Hui Quan, Xuezhou Mao, Joshua Chen, et al.
Contemporary Clinical Trials
|
April 30, 2017
Example-based illustrations of design, conduct, analysis and result interpretation of multi-regional clinical trials
Hui Quan, Xuezhou Mao, Yoko Tanaka, et al.
Page
of 2